HRAS and head and neck squamous cell carcinoma: Oncogenic driver mutations in genes commonly associated with HNSCC, like P53, PI3-AKT pathway, HRAS, CCND1 and others, have been associated with poor survival and have been identified as important factors for outcome predictions in HNSCC cohorts (4, 8).